Cantitate/Preț
Produs

Advances in Microbiology, Infectious Diseases and Public Health: Volume 15: Advances in Experimental Medicine and Biology, cartea 1323

Editat de Gianfranco Donelli
en Limba Engleză Hardback – 13 apr 2021
This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention.
The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs.Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus,EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2019 Impact Factor: 2.450. 
5 Year Impact Factor: 2.324; Cite Score: 3.0;
Eigenfactor Score: 0.03583; Article Influence Score: 0.603
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (9) 63400 lei  6-8 săpt.
  Springer International Publishing – 14 iun 2018 63400 lei  6-8 săpt.
  Springer International Publishing – 24 apr 2018 63400 lei  6-8 săpt.
  Springer International Publishing – 19 dec 2020 70894 lei  6-8 săpt.
  Springer International Publishing – 8 feb 2019 70914 lei  6-8 săpt.
  Springer International Publishing – 14 apr 2022 71115 lei  6-8 săpt.
  Springer International Publishing – 4 aug 2018 89251 lei  6-8 săpt.
  Springer International Publishing – 6 mai 2023 89898 lei  6-8 săpt.
  Springer International Publishing – 31 mai 2018 99360 lei  6-8 săpt.
  Springer International Publishing – 5 aug 2021 108912 lei  6-8 săpt.
Hardback (10) 64153 lei  6-8 săpt. +2483 lei  7-13 zile
  Springer International Publishing – 5 mai 2022 82042 lei  3-5 săpt. +2483 lei  7-13 zile
  Springer International Publishing – 5 oct 2016 64153 lei  6-8 săpt.
  Springer International Publishing – 8 apr 2016 64153 lei  6-8 săpt.
  Springer International Publishing – 19 dec 2019 71737 lei  6-8 săpt.
  Springer International Publishing – 26 iun 2017 84427 lei  6-8 săpt.
  Springer International Publishing – 6 iun 2023 86570 lei  39-44 zile
  Springer International Publishing – 13 apr 2021 90901 lei  6-8 săpt.
  Springer International Publishing – 8 iul 2016 100087 lei  6-8 săpt.
  Springer International Publishing – 28 mai 2018 103301 lei  6-8 săpt.
  Springer International Publishing – 4 aug 2020 109754 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 90901 lei

Preț vechi: 95684 lei
-5% Nou

Puncte Express: 1364

Preț estimativ în valută:
17398 18095$ 14580£

Carte tipărită la comandă

Livrare economică 13-27 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030712013
ISBN-10: 303071201X
Pagini: 162
Ilustrații: VI, 162 p. 1 illus. With online files/update.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.52 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Advances in Microbiology, Infectious Diseases and Public Health

Locul publicării:Cham, Switzerland

Cuprins

Differential Immune Response of Lactobacillus plantarum 286 Against Salmonella Typhimurium Infection in Conventional and Germ-Free Mice.- Evaluation of Microbial Growth in Hospital Textiles Through Challenge Test.- The Role of Gram-Negative Bacteria in Urinary Tract Infections: Current Concepts and Therapeutic Options.- Diffusion and Characterization of Pseudomonas aeruginosa Aminoglycoside Resistance in an Italian Regional Cystic Fibrosis Centre.- Synovial Fluid Mediated Aggregation of Clinical Strains of Four Enterobacterial Species.- Keyboard contamination in Intensive Care Unit: is cleaning enough? Prospective research of in situ effectiveness of a tea tree oil (KTEO) film.- Procalcitonin in the Assessment of Ventilator Associated Pneumonia: A Systematic Review.- Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.- The Ability of a Concentrated Surfactant Gel to Reduce an Aerobic, Anaerobic and Multispecies Bacterial Biofilm In Vitro.

Notă biografică

Gianfranco Donelli obtained his master degree in Biological Sciences from the Sapienza University of Rome in 1966. From 1967 onwards he worked as researcher at the Istituto Superiore di Sanità (ISS - Italian National Institute of Health) in Rome in the field of molecular biology and ultrastructure of bacteriophages and human intestinal viruses. In 1975 he was appointed Director of the Electron Microscopy Unit and in 1979 he became the Research Director in molecular biology. In 1982 he founded the Laboratory of Ultrastructures of ISS that has been led by him till 1996. In those years his main research interests covered many aspects of cellular microbiology with special reference to the mechanism of action and the pathogenetic role of toxins and other bacterial virulence factors. He has been invited since 1977 to serve as visiting professor in the Universities of Ancona, Naples, Perugia, Rome and Urbino and in 1999, he was appointed full Professor of Microbiology.In thelast two decades Professor Donelli has been appointed Coordinator of the Infectious Diseases Research Project of ISS (1991-1995); Vice-President of the Advisory Committee for Biological and Medical Sciences of the Italian National Research Council (1994 - 1999); International Affairs Officer of the Italian Society of Microbiology and FEMS delegate (2002 - today); President of the Society for Microbial Ecology and Disease (2006 - 2009) and Vice-Chairperson of the Executive Committee of ESCMID Study Group for Biofilms (2009 - 2013). His recent research activity has been mainly focused on biofilm-based healthcare-associated infections and the possible strategies to prevent and counteract the development of microbial biofilms in the human body. Professor Donelli is the author of over 200 full-length papers published in international journals (H-index = 38) and editor of multiple books. Since 2010 he is the Director of the Microbial Biofilm Laboratory at the Fondazione Santa Lucia researchhospital in Rome.

Textul de pe ultima copertă

This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention.
The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs.
Advances in Microbiology, Infectious Diseases and Public Health is a subseries of Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences. 2019 Impact Factor: 2.450. 
5 Year Impact Factor: 2.324; Cite Score: 3.0;
Eigenfactor Score: 0.03583; Article Influence Score: 0.603

Caracteristici

Provides state-of-the-art information about infectious diseases affecting humans and animals Gives updates on biofilm prevention and biofilm removal Addresses the epidemiology and pathogenesis of emerging and re-emerging microbial infections Informs on the new strategies for treatment of acute and chronic microbial infections Promotes prompt validation and transfer of the most promising experimental results at the clinical level